All Stories

  1. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status
  2. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma—biomarkers of potential utility?
  3. Skin cancer, photoprotection, and skin of color
  4. Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma
  5. Disseminated Noninterstitial Granulomatous Dermatitis as a Cutaneous Manifestation of the Preleukemic State in a Patient With Myelodysplasia and Ulcerative Colitis—Apropos a Case and Review of the Literature
  6. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases
  7. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
  8. Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma – implications for therapeutic strategies and targeted therapies
  9. Fever and a Solitary Papule on the Foot
  10. Nodular B-Lymphocyte Reactive Patterns: Reactive Nodular B-Cell Pattern
  11. Marginality, aspiration and accessibility in ICTD
  12. Dermatopathology, then and now – have we travelled?
  13. Apoptosis and In Situ and Invasive Squamous Cell Carcinoma in Sun-Exposed Sites
  14. ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B
  15. Cutaneous Adverse Events to Type I BRAF Inhibitors: An Analysis of Effects Associated with Each Inhibitor and Therapeutic Time Interval to Onset
  16. c-myc and Cutaneous Vascular Neoplasms
  17. Mast cells in cutaneous tumors: innocent bystander or maestro conductor?
  18. Porocarcinoma: an exceedingly rare tumor or a tumor eclipse phenomenon?—Reply
  19. Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma
  20. The Grenz Zone
  21. Technology as a tool to develop problem-solving skills in general chemistry
  22. Expression of Gelatinases (MMP-2, MMP-9) and Gelatinase Activator (MMP-14) in Actinic Keratosis and in In Situ and Invasive Squamous Cell Carcinoma
  23. c‐myc in Kaposi’s sarcoma: analyses by fluorescent in situ hybridization and immunohistochemistry
  24. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma
  25. Matrix Metalloproteinases in Health and Disease: Insights From Dermatopathology
  26. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma
  27. Cutaneous Clear Cell Neoplasms
  28. Reactive granular histiocytosis secondary to arthroplasty prosthesis: a novel reaction pattern
  29. Human papillomavirus and cutaneous squamous cell carcinoma: the dilemma continues
  30. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal
  31. Levamisole-Induced Vasculopathy
  32. Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphoma
  33. Adenomatous Eccrine Metaplasia—A Novel Reaction Pattern
  34. Lack of Correlation Between Immunohistochemical Expression of CKIT and KIT Mutations in Atypical Acral Nevi
  35. Stem Cells in the Skin
  36. Psoriatic alopecia - fact or fiction? A clinicohistopathologic reappraisal
  37. Methodology matters, but…
  38. Nests with numerous SOX10 and MiTF-positive cells in lichenoid inflammation: pseudomelanocytic nests or authentic melanocytic proliferation?
  39. Molecular Diagnostics—An Emerging Frontier in Dermatopathology
  40. Laser Capture Microdissection: Methods and Applications
  41. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi
  42. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions
  43. Expression of Stem-Cell Markers (Cytokeratin 15 and Nestin) in Primary Adnexal Neoplasms-Clues to Etiopathogenesis
  44. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma
  45. Desmoplasia: not always a bad thing
  46. Anaplastic Kaposi's sarcoma: an uncommon histologic phenotype with an aggressive clinical course
  47. Nestin-Positive Stem Cells in Neurofibromas From Patients With Neurofibromatosis Type 1-Tumorigenic or Incidental?
  48. Epidermotropic Metastatic Mucoepidermoid Carcinoma
  49. D2-40 Expression in Primary Scarring and Nonscarring Alopecia
  50. Perineural Involvement: What Does it Mean?
  51. Atypical Granular Cell Tumor-Apropos of a Case With Indeterminate Malignant Potential
  52. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?
  53. Role for IGFBP7 in Senescence Induction by BRAF
  54. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin
  55. When Dead Cells Tell Tales-Cutaneous Involvement by Precursor T-Cell Acute Lymphoblastic Lymphoma With an Uncommon Phenotype
  56. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations
  57. Immunohistochemistry in the diagnosis of cutaneous neoplasms
  58. Proliferative Nodules in Congenital Nevi - A Histopathologic, Genetic and Immunohistochemical Reappraisal
  59. Tumor of the Follicular Infundibulum: An Epidermal Reaction Pattern?
  60. Morphometric analyses of elastic tissue fibers in dermatofibroma: clues to etiopathogenesis?
  61. When a negative is a positive!
  62. Cutaneous sebaceous neoplasms as markers of Muir‐Torre syndrome: a diagnostic algorithm
  63. Involvement of the bulge region in primary scarring alopecia
  64. Congenital Darier disease
  65. Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
  66. Quality assurance and continuing medical education in dermatopathology – the ASDP way
  67. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome
  68. Microcystic adnexal carcinoma: an immunohistochemical reappraisal
  69. Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7
  70. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans
  71. Clinicopathologic challenge
  72. CD99 – much ado about nothing?*
  73. Nodular vasculitis – a novel cutaneous manifestation of autoimmune colitis
  74. Histopathology of Gottron’s papules – utility in diagnosing dermatomyositis
  75. Acanthomatous superficial sebaceous hamartoma? A study of six cases with clarification of the nomenclature
  76. Ductal eccrine carcinoma with squamous differentiation: apropos a case
  77. The structure of the human hair follicle
  78. Verrucous carcinoma of the scalp
  79. Pruritic Patches on the Back and Papules on the Legs—Quiz Case
  80. Cutaneous oncocytoma – a report of three cases and review of the literature
  81. Massive exophytic abscesses and fibrotic masses of the chin: A variant of the follicular occlusion triad
  82. Morphea-Like Tattoo Reaction
  83. Amyloidosis of the Auricular Concha: An Uncommon Variant of Localized Cutaneous Amyloidosis
  84. Atypical Pilar Leiomyoma
  85. Expression of PGP 9.5 in granular cell nerve sheath tumors: an immunohistochemical study of six cases
  86. Tumor of the follicular infundibulum with sebaceous differentiation
  87. Intra‐epidermal and intra‐dermal sebocrine adenoma with cystic degeneration and hemorrhage
  88. Letter to the editor
  89. CD29: True Marker of “Memory”?
  90. Right of overseas doctors to practise in the UK
  91. Epstein-Barr virus and autoimmune hepatitis
  92. Co-expression of CD45RA (naive) and CD45RO (memory) T-cell markers